BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36683296)

  • 1. Identifying problematic opioid use in electronic health record data: Are we looking in the right place?
    Schirle L; Kwun S; Suh A; Sanchez-Roige S; Jeffery AD; Samuels DC
    J Opioid Manag; 2023; 19(1):5-9. PubMed ID: 36683296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of problem opioid use in patients receiving chronic opioid therapy: computer-assisted review of electronic health record clinical notes.
    Palmer RE; Carrell DS; Cronkite D; Saunders K; Gross DE; Masters E; Donevan S; Hylan TR; Von Kroff M
    Pain; 2015 Jul; 156(7):1208-1214. PubMed ID: 25760471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid prescribing by physicians with and without electronic health records.
    Harle CA; Cook RL; Kinsell HS; Harman JS
    J Med Syst; 2014 Nov; 38(11):138. PubMed ID: 25300237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtypes in patients with opioid misuse: A prognostic enrichment strategy using electronic health record data in hospitalized patients.
    Afshar M; Joyce C; Dligach D; Sharma B; Kania R; Xie M; Swope K; Salisbury-Afshar E; Karnik NS
    PLoS One; 2019; 14(7):e0219717. PubMed ID: 31310611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using natural language processing to identify opioid use disorder in electronic health record data.
    Singleton J; Li C; Akpunonu PD; Abner EL; Kucharska-Newton AM
    Int J Med Inform; 2023 Feb; 170():104963. PubMed ID: 36521420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: Challenges and opportunities.
    Osterhage KP; Hser YI; Mooney LJ; Sherman S; Saxon AJ; Ledgerwood M; Holtzer CC; Gehring MA; Clingan SE; Curtis ME; Baldwin LM
    Addiction; 2024 Jan; 119(1):160-168. PubMed ID: 37715369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of opioid use disorder using electronic health records: Beyond diagnostic codes.
    Poulsen MN; Nordberg CM; Troiani V; Berrettini W; Asdell PB; Schwartz BS
    Drug Alcohol Depend; 2023 Oct; 251():110950. PubMed ID: 37716289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Future Chronic Opioid Use Among Hospitalized Patients.
    Calcaterra SL; Scarbro S; Hull ML; Forber AD; Binswanger IA; Colborn KL
    J Gen Intern Med; 2018 Jun; 33(6):898-905. PubMed ID: 29404943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated prediction of risk for problem opioid use in a primary care setting.
    Hylan TR; Von Korff M; Saunders K; Masters E; Palmer RE; Carrell D; Cronkite D; Mardekian J; Gross D
    J Pain; 2015 Apr; 16(4):380-7. PubMed ID: 25640294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two data-driven approaches to identifying the spectrum of problematic opioid use: A pilot study within a chronic pain cohort.
    Schirle L; Jeffery A; Yaqoob A; Sanchez-Roige S; Samuels DC
    Int J Med Inform; 2021 Dec; 156():104621. PubMed ID: 34673309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient aberrant drug taking behaviors in a large family medicine residency program: a retrospective chart review of screening practices, incidence, and predictors.
    Lewis M; Herndon CM; Chibnall JT
    J Opioid Manag; 2014; 10(3):169-75. PubMed ID: 24944067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term opioid users with chronic noncancer pain: Assessment of opioid abuse risk and relationship with healthcare resource use.
    Coutinho AD; Gandhi K; Fuldeore RM; Landsman-Blumberg PB; Gandhi S
    J Opioid Manag; 2018; 14(2):131-141. PubMed ID: 29733099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Effectiveness of Decision Support for Prescribing Opioids for Chronic Noncancer Pain: A Prospective Cohort Study.
    Price-Haywood EG; Burton J; Burstain T; Harden-Barrios J; Lefante J; Shi L; Jamison RN; Bazzano A; Bazzano L
    Value Health; 2020 Feb; 23(2):157-163. PubMed ID: 32113620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Potentially Inappropriate Prescribing of Opioid Analgesics Requiring Prior Opioid Tolerance.
    Jeffery MM; Chaisson CE; Hane C; Rumanes L; Tucker J; Hang L; McCoy R; Chen CL; Bicket MC; Hooten WM; Larochelle M; Becker WC; Kornegay C; Racoosin JA; Sanghavi D
    JAMA Netw Open; 2020 Apr; 3(4):e202875. PubMed ID: 32293684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the opioid risk tool to predict aberrant drug-related behavior in patients receiving opioids for the treatment of chronic pain.
    Witkin LR; Diskina D; Fernandes S; Farrar JT; Ashburn MA
    J Opioid Manag; 2013; 9(3):177-87. PubMed ID: 23771568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Misuse and Dependence Screening Practices Prior to Surgery.
    Thiesset HF; Schliep KC; Stokes SM; Valentin VL; Gren LH; Porucznik CA; Huang LC
    J Surg Res; 2020 Aug; 252():200-205. PubMed ID: 32283333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automatically identifying opioid use disorder in non-cancer patients on chronic opioid therapy.
    Zhu VJ; Lenert LA; Barth KS; Simpson KN; Li H; Kopscik M; Brady KT
    Health Informatics J; 2022; 28(2):14604582221107808. PubMed ID: 35726687
    [No Abstract]   [Full Text] [Related]  

  • 18. The Concordance of Electronic Health Record Diagnoses and Substance use Self-Reports Among Reproductive Aged Women Enrolled in a Community-Based Addiction Reduction Program.
    Campbell AG; Naz S; Gharbi S; Chambers J; Denne S; Litzelman DK; Wiehe SE
    Inquiry; 2024; 61():469580241237051. PubMed ID: 38528783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid dose risk, clinician and patient characteristics, and adherence to opioid prescribing recommendations in chronic non-cancer pain.
    Coleman C; Lennon RP; Robinson JM; Tuan WJ; Sehgal N; Zgierska AE
    J Opioid Manag; 2023; 19(5):413-422. PubMed ID: 37968975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid tolerance and urine drug testing among initiates of extended-release or long-acting opioids in Food and Drug Administration's Sentinel System.
    Larochelle MR; Cocoros NM; Popovic J; Dee EC; Kornegay C; Ju J; Racoosin JA
    J Opioid Manag; 2017; 13(5):315-327. PubMed ID: 29199397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.